Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study

Abstract Background Despite the effectiveness of the various targeted therapies currently approved for solid tumors, acquired resistance remains a persistent problem that limits the ultimate effectiveness of these treatments. Polyclonal resistance to targeted therapy has been described in multiple s...

詳細記述

書誌詳細

主要な著者:	Arnaud Bayle, Laila Belcaid, Lola-Jade Palmieri, Diego Teysonneau, Sophie Cousin, Mariella Spalato-Ceruso, Mihaela Aldea, Damien Vasseur, Melissa Alame, Laura Blouin, Isabelle Soubeyran, Claudio Nicotra, Maud Ngocamus, Antoine Hollebecque, Yohann Loriot, Benjamin Besse, Ludovic Lacroix, Etienne Rouleau, Fabrice Barlesi, Fabrice Andre, Antoine Italiano
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-11-01
シリーズ:	Molecular Cancer
主題:	ctDNA Targeted therapy Resistance biomarkers Next-generation sequencing
オンライン･アクセス:	https://doi.org/10.1186/s12943-023-01878-9
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!